Companies / Arcutis Biotherapeutics, Inc. / Activity
Activity — Arcutis Biotherapeutics, Inc.
45 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Leonard Keith R Director | Sell | Common Stock | $997.2K | -39K -63.97% | 22,123 0.02% of shares | medium |
| Mar 2, 2026 | Watanabe Todd Executive | Sell | Common Stock | $912.9K | -36K -4.41% | 787,025 0.63% of shares | medium |
| Feb 2, 2026 | Watanabe Todd Executive | Sell | Common Stock | $505.7K | -20K -2.68% | 721,306 0.57% of shares | medium |
| Feb 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $489.1K | -19K -14.45% | 114,717 0.09% of shares | medium |
| Jan 2, 2026 | Welgus Howard G. Director | Sell | Common Stock | $289.6K | -10K -12.54% | 69,744 0.06% of shares | medium |
| Mar 2, 2026 | Welgus Howard G. Director | Sell | Common Stock | $256.5K | -10K -16.74% | 49,744 0.04% of shares | medium |
| Feb 4, 2026 | Burnett Patrick Executive | Sell | Common Stock | $252.7K | -10K -10.83% | 80,651 0.06% of shares | medium |
| Feb 2, 2026 | Welgus Howard G. Director | Sell | Common Stock | $250.5K | -10K -14.34% | 59,744 0.05% of shares | medium |
| Mar 2, 2026 | Leonard Keith R Director | Exercise | Common Stock | $233.5K | +27K +122.28% | 49,175 0.04% of shares | low |
| Feb 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $213.8K | -9K -6.00% | 134,096 0.11% of shares | medium |
| Feb 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $203.6K | -8K -5.30% | 142,658 0.11% of shares | medium |
| Mar 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $164.9K | -7K -4.56% | 137,125 0.11% of shares | medium |
| Mar 2, 2026 | Burnett Patrick Executive | Sell | Common Stock | $153.6K | -6K -4.79% | 121,295 0.10% of shares | medium |
| Feb 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $120.8K | -5K -4.11% | 110,003 0.09% of shares | medium |
| Feb 2, 2026 | Burnett Patrick Executive | Sell | Common Stock | $93.7K | -4K -3.90% | 90,445 0.07% of shares | low |
| Feb 27, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $92.9K | -3K -2.26% | 143,678 0.11% of shares | low |
| Mar 2, 2026 | Leonard Keith R Director | Exercise | Common Stock | $91.8K | +12K +24.85% | 61,395 0.05% of shares | low |
| Mar 2, 2026 | Edwards Larry Todd Executive | Sell | Common Stock | $90.2K | -4K -2.00% | 175,281 0.14% of shares | low |
| Jan 5, 2026 | Burnett Patrick Executive | Sell | Common Stock | $72.2K | -2K -2.58% | 94,120 0.07% of shares | low |
| Mar 2, 2026 | Vairavan Latha Executive | Sell | Common Stock | $69.7K | -3K -3.06% | 87,835 0.07% of shares | low |
| Feb 2, 2026 | Edwards Larry Todd Executive | Sell | Common Stock | $52.3K | -2K -1.36% | 148,865 0.12% of shares | low |
| Mar 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $51.1K | -2K -1.43% | 136,932 0.11% of shares | low |
| Dec 31, 2025 | Burnett Patrick Executive | Sell | Common Stock | $34.0K | -1K -1.18% | 96,610 0.08% of shares | low |
| Feb 2, 2026 | Vairavan Latha Executive | Sell | Common Stock | $33.7K | -1K -2.03% | 63,607 0.05% of shares | low |
| Mar 2, 2026 | Watanabe Todd Executive | Sell | Common Stock | $27.7K | -1K -0.14% | 785,957 0.63% of shares | low |
| Dec 31, 2025 | Burnett Patrick Executive | Sell | Common Stock | $15.6K | -541 -0.55% | 97,766 0.08% of shares | low |
| Mar 2, 2026 | Matsuda Masaru Executive | Sell | Common Stock | $5.0K | -193 -0.14% | 136,932 0.11% of shares | low |
| Mar 2, 2026 | Burnett Patrick Executive | Sell | Common Stock | $4.7K | -181 -0.15% | 121,150 0.10% of shares | low |
| Mar 2, 2026 | Edwards Larry Todd Executive | Sell | Common Stock | $2.7K | -103 -0.06% | 175,178 0.14% of shares | low |
| Mar 2, 2026 | Vairavan Latha Executive | Sell | Common Stock | $2.1K | -81 -0.09% | 87,754 0.07% of shares | low |
| Jun 5, 2026 | Heron Patrick J Director | Grant | Common Stock | $0 | +6K +21.86% | 32,213 0.03% of shares | low |
| Feb 27, 2026 | Watanabe Todd Executive | Grant | Common Stock | $0 | +102K +14.14% | 823,306 0.66% of shares | low |
| Feb 27, 2026 | Matsuda Masaru Executive | Grant | Common Stock | $0 | +37K +33.64% | 147,003 0.12% of shares | low |
| Feb 27, 2026 | Edwards Larry Todd Executive | Grant | Common Stock | $0 | +30K +20.15% | 178,865 0.14% of shares | low |
| Feb 27, 2026 | Vairavan Latha Executive | Grant | Common Stock | $0 | +27K +42.45% | 90,607 0.07% of shares | low |
| Feb 27, 2026 | Burnett Patrick Executive | Grant | Common Stock | $0 | +30K +30.80% | 127,401 0.10% of shares | low |
| Aug 18, 2022 | Burnett Patrick Executive | Grant | Common Stock | $0 | +17K +20.77% | 97,401 0.08% of shares | low |
| Jun 5, 2026 | Heron Patrick J Director | Grant | Stock Option (right to buy) | — | +17K | 16,667 0.01% of shares | low |
| Feb 27, 2026 | Watanabe Todd Executive | Grant | Stock Option (right to buy) | — | +266K | 266,000 0.21% of shares | low |
| Feb 27, 2026 | Matsuda Masaru Executive | Grant | Stock Option (right to buy) | — | +97K | 97,000 0.08% of shares | low |
| Mar 2, 2026 | Leonard Keith R Director | Exercise | Stock Option (right to buy) | — | -12K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Leonard Keith R Director | Exercise | Stock Option (right to buy) | — | -27K -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Edwards Larry Todd Executive | Grant | Stock Option (right to buy) | — | +77K | 77,000 0.06% of shares | low |
| Feb 27, 2026 | Vairavan Latha Executive | Grant | Stock Option (right to buy) | — | +70K | 70,000 0.06% of shares | low |
| Feb 27, 2026 | Burnett Patrick Executive | Grant | Stock Option (right to buy) | — | +77K | 77,000 0.06% of shares | low |